$24.22
-0.0021%Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
WRBY โข NYSE
| Warby Parker Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||||
1.6M | -20.4M | -63.2M | -110.4M | -144.3M | -55.9M | -57.5M | |
50.3M | 45.9M | 38.6M | 31.9M | 21.9M | 18.4M | 14.5M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -85.3M | 0.0 | |
34.5M | 47.3M | 70.5M | 98M | 107.1M | 44.9M | 8.5M | |
6.8M | 6.7M | 9.3M | 5.4M | 7.8M | 85.3M | 57.5M | |
(0.0) | (0.0) | (419K) | (536K) | (356K) | (230K) | (369K) | |
17.5M | 19.3M | 5.8M | -14.6M | -24.5M | 25.4M | -1.6M | |
110.8M | 98.7M | 61M | 10.4M | -32M | 32.8M | 21.4M | |
INVESTING ACTIVITIES | |||||||
-67M | -64M | -53.7M | -60.2M | -48.5M | -20.1M | -32.6M | |
(0.0) | -2M | -1M | (0.0) | (0.0) | (0.0) | (0.0) | |
-67M | -66M | -54.7M | -60.2M | -48.5M | -20.1M | -32.6M | |
FINANCING ACTIVITIES | |||||||
2.4M | 4.6M | 2.9M | 3.2M | -8.1M | 245M | -79.5M | |
0.0 | 0.0 | 0.0 | 91K | 31.6M | 945K | 0.0 | |
(0.0) | (0.0) | (0.0) | (0.0) | -8.1M | (0.0) | -79.5M | |
-14.4M | 333K | 0.0 | 0.0 | -528K | 0.0 | -3.9M | |
-12M | 5M | 2.9M | 3.3M | 23M | 245.9M | -83.4M | |
CASH FLOW SUMMARY | |||||||
457K | -406K | -882K | -1.3M | -161K | 37K | 237K | |
32.2M | 37.3M | 8.3M | -47.8M | -57.7M | 258.7M | -94.4M | |
254.2M | 216.9M | 208.6M | 256.4M | 314.1M | 55.4M | 149.8M | |
286.4M | 254.2M | 216.9M | 208.6M | 256.4M | 314.1M | 55.4M | |
43.7M | 34.7M | 7.3M | -49.8M | -80.5M | 12.7M | -11.2M |
WRBY - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 08, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | February 26, 2026 | February 26, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 09, 2026 | February 04, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 08, 2025 | December 08, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
10-Q 10-Q 2025 Q2 Q2 | August 08, 2025 | June 30, 2025 | 2025 |
Continue your WRBY research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.